AdaptHealth Corp.

AHCO Healthcare Medical Devices

Revenue
+10.9%
EPS
−758.8%
Free cash flow
−23.6%
Total debt
+6.85%

Quarter to September 2026, against a year earlier

7.33 0.08 −1.08%
Market cap
$1.0B
P/E
0.0×
Fwd P/E
−4.6×
Dividend yield
—
F-score
4/9
Altman Z
0.91
Beneish M
−3.26
Dividend safety
n/a

AdaptHealth Corp. (AHCO) P/E ratio

Alert me on P/E ratio

AdaptHealth Corp. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 980× (June 2018) — the current reading is the lowest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 15.6× —
FY2023 0.0× —
FY2022 40.3× 84.49%
FY2021 21.8× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 4.8× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 0.0× —
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
27 more quarters

Against its own ten years

Low 0.0× High 980×
Ten-year median 4.9×
Current reading's percentile 49

P/E ratio against peers

Company P/E ratio
CBLL CeriBell, Inc. compare n/m
BBNX Beta Bionics, Inc. compare n/m
AHCO AdaptHealth Corp. n/m
SIBN SiBone compare n/m
QDEL QuidelOrtho Corporation compare n/m
KIDS OrthoPediatrics Corp. compare n/m
BVS Bioventus Inc. compare 12.3×
IRMD iRadimed Corporation compare 44.9×
IART Integra LifeSciences Holdings Corporation compare 83.0×
Medical Devices industry median 25.6×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on AHCO